Basilea Pharmaceutica AG (BSLN.SW)
CHF 41.65
(0.24%)
CHF 41.65
(0.24%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 14.24 Million | 7.05 Million | -32.02 Million | -54.13 Million | -63.83 Million | -79.21 Million |
| Net Income | 10.45 Million | 12.14 Million | -6.83 Million | -14.72 Million | -22.42 Million | -31.35 Million |
| Depreciation & Amortization | 3.47 Million | 3.09 Million | 2.45 Million | 2.29 Million | 1.63 Million | 1.75 Million |
| Deferred income taxes | -4.77 Million | -19.09 Million | -45.42 Million | -8.45 Million | -3.63 Million | -8.09 Million |
| Stock-based compensation | 4.76 Million | 3.59 Million | 4.32 Million | 3.52 Million | 3.04 Million | 6.3 Million |
| Change in working capital | -4.31 Million | -11.72 Million | -31.78 Million | -30.76 Million | -46.85 Million | 1.79 Million |
| Other non-cash items | 4.64 Million | 19.03 Million | 45.24 Million | -6.01 Million | 4.39 Million | -49.61 Million |
| Investing Cash Flow | -1.03 Million | 91.64 Million | 3.57 Million | -34.96 Million | -404 Thousand | 59.39 Million |
| Investments in PPE | -1.03 Million | -3.3 Million | -860 Thousand | -2.26 Million | -404 Thousand | -419 Thousand |
| Acquisitions | - | - | -1.58 Million | 18.32 Million | 110 Thousand | - |
| Investment purchases | - | - | -35 Million | -81.02 Million | -50 Million | - |
| Sales/Maturities of investments | - | 94.95 Million | 41.02 Million | 30 Million | 50 Million | 60 Million |
| Other Investing Activities | -221 Thousand | 1000.00 | 15 Thousand | -33.14 Million | -110 Thousand | -190 Thousand |
| Financing Cash Flow | -57.3 Million | -45.24 Million | 16.64 Million | 45.06 Million | 1.3 Million | -5.98 Million |
| Debt repayment | -59.31 Million | -73.87 Million | -23.21 Million | -40.25 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | -472 Thousand | - | -4.25 Million | - | - | -6.23 Million |
| Common Stock Issuance | 2.48 Million | 4.42 Million | 44.1 Million | 4.8 Million | 1.3 Million | 249 Thousand |
| Other Financing Activities | 57.3 Million | 24.2 Million | 23.21 Million | 80.51 Million | 1.3 Million | 249 Thousand |
| Accounts receivables | 3.45 Million | 2.58 Million | -32.06 Million | -4.12 Million | 6.45 Million | 1.05 Million |
| Accounts payables | 5.65 Million | -10.42 Million | -2.53 Million | 6.39 Million | 378 Thousand | 2.05 Million |
| Inventory | -2.16 Million | -1.46 Million | -1.59 Million | -2.61 Million | -4.14 Million | 741 Thousand |
| Other working capital | -11.25 Million | -2.42 Million | 4.4 Million | -30.41 Million | -49.54 Million | -2.05 Million |
| Cash at beginning of period | 36.56 Million | 54.95 Million | 55.6 Million | 54.52 Million | 38.3 Million | 200.72 Million |
| Cash at end of period | 12.48 Million | 36.56 Million | 54.95 Million | 55.6 Million | 54.52 Million | 173.9 Million |
| Capital Expenditure | -1.03 Million | -3.3 Million | -860 Thousand | -2.26 Million | -404 Thousand | -419 Thousand |
| Effect of forex changes on cash | -151 Thousand | 155 Thousand | 501 Thousand | -758 Thousand | 67 Thousand | -1.01 Million |
| Net cash flow / Change in cash | -24.07 Million | -18.38 Million | -654 Thousand | 1.08 Million | 16.21 Million | -26.81 Million |
| Free Cash Flow | 13.21 Million | 3.75 Million | -32.88 Million | -56.39 Million | -64.24 Million | -79.62 Million |
| Breakdown | 2024 Q2 | 2023 FY | 2023 Q4 | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 20.73 Million | 10.45 Million | -21.38 Million | 31.84 Million | 12.14 Million | 24.35 Million |
| Depreciation & Amortization | 1.19 Million | 3.47 Million | 1.72 Million | 1.75 Million | 3.09 Million | 740 Thousand |
| Deferred income taxes | -13.42 Million | -4.77 Million | 1.38 Million | -6.16 Million | -19.09 Million | -30.4 Million |
| Stock-based compensation | 2.5 Million | 4.76 Million | 2.49 Million | 2.26 Million | 3.59 Million | 1.75 Million |
| Change in working capital | 1.15 Million | -4.31 Million | 9.17 Million | -13.49 Million | -11.72 Million | -21.36 Million |
| Other non-cash items | -7.66 Million | 4.64 Million | -1.01 Million | 5.66 Million | 19.03 Million | 31.83 Million |
| Investing Cash Flow | 261 Thousand | -1.03 Million | -645 Thousand | -389 Thousand | 91.64 Million | 93.96 Million |
| Investments in PPE | -467 Thousand | -1.03 Million | -645 Thousand | -389 Thousand | -3.3 Million | -974 Thousand |
| Acquisitions | 781 Thousand | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | 94.99 Million |
| Sales/Maturities of investments | - | - | - | - | 94.95 Million | -49 Thousand |
| Other Investing Activities | 728 Thousand | -221 Thousand | -146 Thousand | -75 Thousand | 1000.00 | 1000.00 |
| Financing Cash Flow | -13.14 Million | -57.3 Million | -40.22 Million | -17.08 Million | -45.24 Million | -38.48 Million |
| Debt repayment | -15.6 Million | -59.31 Million | -18.42 Million | -18.42 Million | -73.87 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -472 Thousand | -384 Thousand | -88 Thousand | - | 165 Thousand |
| Common Stock Issuance | 2.31 Million | 2.48 Million | 1.04 Million | 1.43 Million | 4.42 Million | 4.42 Million |
| Other Financing Activities | 2.46 Million | 57.3 Million | -40.22 Million | 1.34 Million | 24.2 Million | -116.94 Million |
| Accounts receivables | -175 Thousand | 3.45 Million | 6.19 Million | -2.74 Million | 2.58 Million | -23.17 Million |
| Accounts payables | 5.62 Million | 5.65 Million | 1.9 Million | 3.75 Million | -10.42 Million | -4.51 Million |
| Inventory | -4.96 Million | -2.16 Million | -772 Thousand | -1.39 Million | -1.46 Million | 511 Thousand |
| Other working capital | 6.29 Million | -11.25 Million | 1.84 Million | -13.1 Million | -2.42 Million | 5.81 Million |
| Cash at beginning of period | 12.48 Million | 36.56 Million | 90.94 Million | 36.56 Million | 54.95 Million | 46.86 Million |
| Cash at end of period | 69.47 Million | 12.48 Million | 12.48 Million | 90.94 Million | 36.56 Million | 36.56 Million |
| Capital Expenditure | -467 Thousand | -1.03 Million | -645 Thousand | -389 Thousand | -3.3 Million | -974 Thousand |
| Effect of forex changes on cash | 109 Thousand | -151 Thousand | -139 Thousand | -12 Thousand | 155 Thousand | -686 Thousand |
| Net cash flow / Change in cash | 56.98 Million | -24.07 Million | -78.45 Million | 54.38 Million | -18.38 Million | -10.29 Million |
| Free Cash Flow | 17.45 Million | 13.21 Million | -8.26 Million | 21.47 Million | 3.75 Million | 5.93 Million |
3352
TIMB
T-PC
FLORACORP
RBGLY
JPM